New companies funded and major funding events…
Want to get this list of recently funded companies and more data? Fill out a quote request to get more info or set up a call (Quote Request Form)
FIG. 1. Recent Biotech Funding Activity.
– Private Funding –
Zenas BioPharma
💸 Raised $200M in series C financing led by various investors to advance obexelimab development.
Bluejay Therapeutics
💸 Secured $182M in Series C co-led by Frazier Life Sciences to accelerate development of BJT-778.
Attovia Therapeutics
💸 Raised $105m in Series B financing led by Goldman Sachs Alternatives to advance its lead programs and expand the pipeline.
Aardvark Therapeutics
💸 Completed $85M in series C funding led by Decheng Capital to advance the development of ARD-101.
Commit Biologics
💸 Launched with €16M seed financing led by Bioqube Ventures and Novo Holdings to develop its BiCE platform to treat cancer and autoimmune disease.
– Post-IPO/Public Funding –
Organon & Co.
🏦 $1B senior notes offered for secured and unsecured funding rounds at $500M each.
Verona Pharma
🏦 Announced $650M strategic financing with Oaktree and OMERS.
Pacira BioSciences, Inc.
🏦 $250M convertible senior notes offering priced at $39.56/share.
ITeos Therapeutics
🏦 Announced $120M direct offering led by RA Capital Management and Boxer Capital to extend cash runway and to initiate a Ph 3 clinical trial by 2027.
Plus Therapeutics
🏦 To raise $18M private placement w/ participation by AIGH Capital Management LLC to fund the Re-SPECT LM program.
---
Article History:
RF, DV, DG (05/14/24)
This article is not investment or legal advice.
Comments